{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T08:31:32Z","timestamp":1776501092373,"version":"3.51.2"},"reference-count":23,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2001,12,21]],"date-time":"2001-12-21T00:00:00Z","timestamp":1008892800000},"content-version":"vor","delay-in-days":173,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J of Gastro and Hepatol"],"published-print":{"date-parts":[[2001,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Background and Aims:<\/jats:bold> Recently, we found in a portal hypertensive rat model that hemorrhage and volume restitution with Haemaccel, a low viscosity plasma expander, induced an increase in cardiac output and portal venous inflow. The present study was conducted to evaluate whether pretreatment with propranolol will attenuate these hyperdynamic changes.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> Portal hypertension was induced by portal vein constriction. Treatment was initiated 14\u201321 days later. Propranolol (30 mg\/kg per day) or water were administered for 7 days via a gastric gavage. Under ketamine anesthesia, 18 h after the last given dose, blood was withdrawn at a constant rate of 0.3 mL\/min for 15 min followed by a 15\u2010min stabilization. Haemaccel was infused at the same rate and volume used for withdrawal. Hemodynamic measurements were performed after volume restitution in both groups by using radioactive microspheres.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Eight rats were studied in each group. In the propranolol\u2010treated animals, portal venous inflow was decreased (2.4 \u00b1 0.8 <jats:italic>vs<\/jats:italic> 3.8 \u00b1 0.7 mL\/min per 100 g bodyweight; <jats:italic>P<\/jats:italic> &lt; 0.01), while splanchnic arteriolar and porto\u2010collateral resistance were increased (52.8 \u00b1 21.0 <jats:italic>vs<\/jats:italic> 32.8 \u00b1 13.0 and 6.0 \u00b1 1.4 <jats:italic>vs<\/jats:italic> 4.1 \u00b1 0.7 mmHg \u00d7 min \u00d7 100 g bodyweight\/mL; <jats:italic>P<\/jats:italic> &lt; 0.05, respectively). Cardiac output, mean arterial pressure, heart rate, total peripheral resistance and portal pressure were not significantly different between the two groups.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> In this model, pretreatment with propranolol prevented the increase in portal venous inflow, which occurs following hemorrhage and volume restitution with Haemaccel. Although caution should be taken in extrapolating data from animal models to humans, our results suggest that volume replacement during a portal hypertensive\u2010related bleeding episode may be safer in a patient treated with non\u2010selective \u03b2\u2010adrenoreceptor antagonists.<\/jats:p>","DOI":"10.1046\/j.1440-1746.2001.02514.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T05:20:13Z","timestamp":1047446413000},"page":"796-800","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Systemic and splanchnic hemodynamics following hemorrhage and volume restitution with Haemaccel in portal hypertensive rats: The effect of propranolol"],"prefix":"10.1111","volume":"16","author":[{"given":"Nir","family":"Hilzenrat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arie","family":"Arish","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arieh","family":"Yaari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuel","family":"Sikuler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2001,12,21]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-7125(16)30207-3"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(69)80163-0"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(86)90390-2"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM196610062751403"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.15.2.99"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0168-8278(99)80289-x"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2044.1987.tb05376.x"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(80)90063-X"},{"key":"e_1_2_5_10_2","first-page":"1343","volume-title":"The Liver Biology and Pathobiology","author":"Bosch J","year":"1994"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(00)80422-5"},{"key":"e_1_2_5_12_2","first-page":"G52","article-title":"Hyperdynamic circulation in a portal hypertensive rat model: a primary factor for maintenance of chronic portal hypertension.","volume":"244","author":"Vorobioff J","year":"1983","journal-title":"Am. J. Physiol."},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02208661"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2362.1997.1590708.x"},{"key":"e_1_2_5_15_2","first-page":"G618","article-title":"Evolution of portal hypertension and mechanisms involved in its maintenance in a rat model.","volume":"248","author":"Sikuler E","year":"1985","journal-title":"Am. J. Physiol."},{"key":"e_1_2_5_16_2","first-page":"H443","article-title":"Reference sample microsphere method: cardiac output and blood flows in conscious rats.","volume":"239","author":"Ishise S","year":"1980","journal-title":"Am. J. Physiol."},{"key":"e_1_2_5_17_2","first-page":"G205","article-title":"Interaction of flow and resistance in maintenance of portal hypertension in a rat model.","volume":"250","author":"Sikuler E","year":"1986","journal-title":"Am. J. Physiol."},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840050120"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840090218"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2008-1040614"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1139\/y89-219"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/0168-8278(95)80223-1"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(97)80023-2"},{"key":"e_1_2_5_24_2","first-page":"235","volume-title":"Goodman and Gilman's The Pharmacological Basis of Therapeutics","author":"Hoffman BB","year":"1996"}],"container-title":["Journal of Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1440-1746.2001.02514.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1440-1746.2001.02514.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T15:32:06Z","timestamp":1697643126000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1440-1746.2001.02514.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,7]]},"references-count":23,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2001,7]]}},"alternative-id":["10.1046\/j.1440-1746.2001.02514.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1440-1746.2001.02514.x","archive":["Portico"],"relation":{},"ISSN":["0815-9319","1440-1746"],"issn-type":[{"value":"0815-9319","type":"print"},{"value":"1440-1746","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,7]]},"assertion":[{"value":"2001-12-21","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}